The ASCO 2018 annual meeting: update on the adjuvant treatment of early breast cancer

Clemens Dormann; Karl J. Aichberger

doi:10.1007/s12254-018-0448-3

The ASCO 2018 annual meeting: update on the adjuvant treatment of early breast cancer

memo - Magazine of European Medical Oncology ◽

10.1007/s12254-018-0448-3 ◽

2018 ◽

Vol 11 (4) ◽

pp. 272-275

Author(s):

Clemens Dormann ◽

Karl J. Aichberger

Keyword(s):

Breast Cancer ◽

Annual Meeting ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text

Faculty Opinions recommendation of Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738708663.793581156 ◽

2020 ◽

Author(s):

David Potter

Keyword(s):

Breast Cancer ◽

High Risk ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Node Positive

Download Full-text

Adjuvant treatment of early breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80272-1 ◽

2005 ◽

Vol 3 (3) ◽

pp. 149-166 ◽

Cited By ~ 1

Author(s):

Lissandra Dal Lago ◽

Chantal Bernard-Marty ◽

Martine J. Piccart

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text

S31 Continuous infusional chemotherapy as pre-operative and as adjuvant treatment in early breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)89204-0 ◽

1998 ◽

Vol 34 ◽

pp. S8

Author(s):

I.E. Smith

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text

Spotlight on Trastuzumab as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer†

BioDrugs ◽

10.2165/11204680-000000000-00000 ◽

2010 ◽

Vol 24 (3) ◽

pp. 207-209 ◽

Cited By ~ 2

Author(s):

Karly P. Garnock-Jones ◽

Gillian M. Keating ◽

Lesley J. Scott

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Growth Factor Receptor ◽

Her2 Positive ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

Download Full-text

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results

European Journal of Cancer ◽

10.1016/j.ejca.2018.01.072 ◽

2018 ◽

Vol 93 ◽

pp. 19-27 ◽

Cited By ~ 29

Author(s):

X. Pivot ◽

I. Bondarenko ◽

Z. Nowecki ◽

M. Dvorkin ◽

E. Trishkina ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Reference Product ◽

Phase Iii ◽

Her2 Positive ◽

Phase Iii Study

Download Full-text

CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA

Value in Health ◽

10.1016/j.jval.2019.09.048 ◽

2019 ◽

Vol 22 ◽

pp. S405-S406

Author(s):

X. Guan ◽

H. Li ◽

Q. Chen ◽

C. Hao ◽

J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

High Risk ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Risk Of Recurrence ◽

Effectiveness Analysis

Download Full-text

Leukemia risk after adjuvant treatment of early breast cancer

Women s Health ◽

10.2217/17455057.1.1.73 ◽

2005 ◽

Vol 1 (1) ◽

pp. 73-85 ◽

Cited By ~ 2

Author(s):

Alessandra Balduzzi ◽

Monica Castiglione-Gertsch

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text

PCN20 COST-EFFECTIVENESS ASSESSMENT FOR COLOMBIA OF LETROZOLE VS. TAMOXIFEN IN ADJUVANT TREATMENT OF HORMONE RECEPTOR-POSITIVE, POST-MENOPAUSAL EARLY BREAST CANCER WOMEN

Value in Health ◽

10.1016/s1098-3015(10)75347-x ◽

2009 ◽

Vol 12 (7) ◽

pp. A496

Author(s):

O Gamboa ◽

L Chicaiza ◽

M Garcia

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Hormone Receptor ◽

Hormone Receptor Positive ◽

Post Menopausal ◽

Effectiveness Assessment ◽

Cost Effectiveness Assessment

Download Full-text

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-006-9262-4 ◽

2006 ◽

Vol 101 (1) ◽

pp. 37-49 ◽

Cited By ~ 22

Author(s):

Khalid El Ouagari ◽

Jon Karnon ◽

Thomas Delea ◽

Willena Talbot ◽

Jane Brandman

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text

1941 Is PROSIGNA useful to determine adjuvant treatment in intermediate prognosis early breast cancer (EBC)?

European Journal of Cancer ◽

10.1016/s0959-8049(16)30889-9 ◽

2015 ◽

Vol 51 ◽

pp. S312 ◽

Cited By ~ 1

Author(s):

J. Bonneterre ◽

A. Prat ◽

P. Galvan ◽

S. Giard

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment

Download Full-text